Iradimed Corp.
IRADIMED CORPORATION (Nasdaq: IRMD) develops, manufactures and sells MRI-compatible medical devices, accessories, disposables and related services, primarily to hospitals and acute care facilities. Its products include the MRidium 3870 and 3860+ intravenous infusion pump systems, which deliver fluids and medications… From the company’s description.
Over the twelve months to Sep 30, 2026, Iradimed Corp. reported revenue of $89.34M, up 11.0% from a year earlier, and net income of $23.98M. Its operating margin was 32.3%, and operations generated $27.15M in cash. In fiscal 2025, it reported revenue of $83.81M, up 14.4% from fiscal 2024, and net income of $22.48M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Iradimed Corp. does
In the company’s own words
IRADIMED CORPORATION (Nasdaq: IRMD) develops, manufactures and sells MRI-compatible medical devices, accessories, disposables and related services, primarily to hospitals and acute care facilities. Its products include the MRidium 3870 and 3860+ intravenous infusion pump systems, which deliver fluids and medications in MRI environments; the 3880 patient vital signs monitoring system; and the 3600 FMD1 ferromagnetic detection device with a remote alarm logging unit. The company also sells proprietary single-use IV tubing sets, maintenance agreements and service. IRadimed sells directly in the United States and through independent distributors in approximately 80 countries internationally. It operates as a single business focused on MRI-compatible medical equipment. Revenue was $83.8 million for fiscal 2025. Founded in 1992, the company introduced its first MRI-compatible infusion pump in 2005 and launched the 3880 monitor in 2016; its 3870 pump began customer shipments in 2025. Its website is www.iradimed.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- ORLANDO, FL
- Fiscal year end
- December
- CIK
- 1325618
- SIC
- 3841
Financial performance, year by year
Fiscal 2014–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Iradimed Corp. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Iradimed Corp.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Iradimed Corp. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Iradimed Corp.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Iradimed Corp.'s last four quarterly filings that the numbers alone won't show?”